Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: Effect of immunotherapy

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 4, 2004, Pages 240-250

  Hammoudi Triki, Djélila ^a,b,c   Ferquel, Elisabeth ^b   Robbe Vincent, Annie ^b   Bon, Cassian ^b   Choumet, Valérie ^b   Laraba Djebari, Fatima ^a,c  

^a Institut Pasteur d'Algerie   (Algeria)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

Author keywords

Algeria; Androctonus australis; Antivenom immunotherapy; Clinical gradation; ELISA; Epidemiology; IL6; Scorpion envenomation; Toxicokinetics; Venom quantification

Indexed keywords

INTERLEUKIN 6; SCORPION VENOM; VENOM ANTISERUM;

ALGERIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG POTENCY; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH SURVEY; HOSPITAL ADMISSION; IMMUNOTHERAPY; INFLAMMATION; INSECT STING; MALE; MOUSE; NONHUMAN; PATIENT TRANSPORT; PROCESS OPTIMIZATION; SCORPION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; FEMALE; HUMAN; INFANT; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; SPIDER BITE;

ANDROCTONUS; ANDROCTONUS AUSTRALIS; SCORPIONES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGERIA; ARACHNIDISM; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOTHERAPY; INFANT; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCORPION VENOMS;

EID: 2442460970     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)00062-2     Document Type: Article

References (31)

1. Abroug F. El Atrous S. Nouira S. Haguiga H. Touzi N. Bouchoucha S. Serotherapy in scorpion envenomation: A randomised controlled trial Lancet 354 1999 906-909
2. Audebert F. Grosselet O. Sabouraud A. Bon C. Quantification of venom antigens from European vipers in human serum or urine by ELISA J. Anal. Toxicol. 17 1993 236-240
3. Avrameas F. Ternynck T. 1971. Peroxidase-labelled antibody and Fab conjugate with enhanced intracellular penetration. Immunochemistry 1175-1179.
4. Barraviera B. Systemic inflammatory response syndrome in envenoming [letter; comment] Toxicon 35 1997 13-14
5. Bucher B. Canonge D. Thomas L. Tyburn B. Robbe-Vincent A. Choumet V. Bon C. Ketterle J. Lang J. Clinical indicators of envenoming and serum levels of venom antigens in patients bitten by Bothrops lanceolatus in Martinique. Research Group on Snake Bites in Martinique Trans. R. Soc. Trop. Med. Hyg. 91 1997 186-190
6. Calderon-Aranda E.S. Hozbor D. Possani L.D. Neutralizing capacity of murine sera induced by different antigens of scorpion venom Toxicon 31 1993 327-337
7. 2.Toxicon 37 1999 771-782
8. de Rezende N.A. Dias M.B. Campolina D. Chavez-Olortegui C. Diniz C.R. Amaral C.F. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions Am. J. Trop. Med Hyg. 52 1995a 277-280
9. de Rezende N.A. Dias M.B. Campolina D. Chavez-Olortegui C. Amaral C.F. Standardization of an enzyme linked immunosorbent assay (ELISA) for detecting circulating toxic venom antigens in patients stung by the scorpion Tityus serrulatus Rev. Inst. Med. Trop. Sao Paulo 37 1995b 71-74
10. de Rezende N.A. Amaral C.F. Freire-Maia L. Immunotherapy for scorpion envenoming in Brazil Toxicon 36 1998 1507-1513
11. Ghalim N. El-Hafny B. Sebti F. Heikel J. Lazar N. Moustanir R. Benslimane A. Scorpion envenomation and serotherapy in Morocco Am. J. Trop. Med Hyg. 62 2000 277-283
12. Ismail M. The treatment of the scorpion envenoming syndrome: The Saudi experience with serotherapy Toxicon 32 1994 1019-1026
13. Ismail M. The scorpion envenoming syndrome Toxicon 33 1995 825-858
14. Ismail M. Abd-Elsalam M.A. Are the toxicological effects of scorpion envenomation related to tissue venom concentration? Toxicon 26 1988 233-256
15. Ismail M. Fatani A.J. Dabees T.T. Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitors Toxicon 30 1992 1257-1279
16. Ismail M. Abd-Elsalam M.A. Al-Ahaidib M.S. Androctonus crassicauda (Olivier), a dangerous and unduly neglected scorpion-I. Pharmacological and clinical studies Toxicon 32 1994 1599-1618
17. Krifi M.N. Kharrat H. Zghal K. Abdouli M. Abroug F. Bouchoucha S. Dellagi K. El Ayeb M. Development of an ELISA for the detection of scorpion venoms in sera of humans envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot): Correlation with clinical severity of envenoming in Tunisia Toxicon 36 1998 887-900
18. Krifi M.N. Amri F. Kharrat H. El Ayeb M. Evaluation of antivenom therapy on children severly envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion venom Toxicon 37 1999 1627-1634
19. Krifi M.N. Miled K. Abderrazek M. El Ayeb M. Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: Towards an optimisation of antivenom immunotherapy in a rabbit model Toxicon 39 2001 1317-1326
20. Laraba-Djebari F. Hammoudi-Triki D. Utilisation de la Fraction toxique majoritaire isolée à partir du venin d' Androctonus australis hector d'Algérie dans la valorisation du sérum anti-scorpionique Archives de l'Institut Pasteur d'Algérie 62 1998 254-266
21. 2) à partir d'un sérum anti-scorpionique Arch. Inst. Pasteur Algérie 63 1999 7-24
22. Lomonte B. Tarkowski A. Hanson L.A. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model Inflammation 17 1993 93-105
23. Magalhaes M.M. Pereira M.E. Amaral C.F. Rezende N.A. Campolina D. Bucaretchi F. Gazzinelli R.T. Cunha-Melo J.R. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting Toxicon 37 1999 1155-1164
24. Meki A.R. Mohey El-Dean Z.M. Serum interleukin-6, nitric oxide and a α1-antitrypsin in scorpion envenomed children Toxicon 36 1998 1851-1859
25. Possani L.D. Antivenom for scorpion sting Lancet 355 2000 66-67
26. Revelo M.P. Bambira E.A. Ferreira A.P. Diniz C.R. Chavez-Olortegui C. Body distribution of Tityus serrulatus scorpion venom in mice and effects of scorpion antivenom Toxicon 34 1996 1119-1125
27. Rivière G. Choumet V. Audebert F. Sabouraud A. Debray M. Scherrmann J.M. Bon C. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: Toward an optimization of antivenom J. Pharmacol. Exp. Ther. 281 1997 1-8
28. Sofer S. Gueron M. White R.M. Lifshitz M. Apte R.N. Interleukin-6 release following scorpion sting in children Toxicon 34 1996 389-392
29. Theakston R.D. Lloyd-Jones M.J. Reid H.A. Micro-ELISA for detecting and assaying snake venom antibody Lancet 2 1977 639-641
30. Voronov E. Apte R.N. Sofer S. The systemic inflammatory response syndrome related to the release of cytokines following severe envenomation J. Ven. Anim. Tox. 5 1999 1-38
31. WHO, 1981. Caractérisation des venins et standardisation des serums antivenimeux: progrés realisés. Organisation Mondiale de la Santé, Genève, offset publication No. 58